Behavioral effect |
Rats can be trained to discriminate hallucinogens from vehicle. |
Rats and mice treated with hallucinogens express the HTR. |
Hallucinogens reduce PPI in rats. |
Hallucinogens reduce exploratory and investigatory behavior in rats. |
Receptor mechanism for phenylalkylamine hallucinogens (eg, mescaline) |
Selective 5-HT2A receptor antagonists (eg, M100907 and MDL 11,939) block the effect. |
Selective 5-HT2A receptor antagonists (eg, M100907 and MDL 11,939) block the effect. |
Selective 5-HT2A receptor antagonists (eg, M100907 and MDL 11,939) block the effect. |
Selective 5-HT2A receptor antagonists (eg, M100907 and MDL 11,939) block the effect. |
Receptor mechanism for indoleamine hallucinogens (eg, LSD and psilocybin) |
The mechanism for the DD effects for tryptamine hallucinogens often mediated by both 5-HT1A and 5-HT2A receptors. The mechanism for the effect of LSD is time-dependent; at short intervals between injection and testing (eg, 15–30 min), the effect of LSD is blocked by selective 5-HT2A antagonists; however, if the interval is increased to 90 min then the effect of LSD is blocked by antagonists of D2-like receptors. |
Selective 5-HT2A receptor antagonists (eg, M100907 and MDL 11,939) block the effect. |
Selective 5-HT2A receptor antagonists (eg, M100907 and MDL 11,939) block the effect. |
Indoleamine hallucinogens act through both 5-HT1A and 5-HT2A receptor mechanisms. |
Sensitivity to lisuride |
Lisuride produces hallucinogen-like effects in some DD studies but not in others. |
Lisuride does not induce the HTR in rats or mice. |
Lisuride reduces PPI in rats but the effect is mediated by D2/3 receptors rather than the 5-HT2A receptor. |
Lisuride does not produce LSD-like effects on exploratory or investigatory behavior in rats. |